How Long Should You Stay in an SIP?

About this episode

The episode discusses the duration of SIP investments and insights from a study on mutual funds.

Every month, millions of Indians put money into mutual funds through SIPs without really knowing how long to stay invested or what happens when markets crash. ET Wealth's annual SIP study with Crisil Intelligence finally puts hard numbers to these questions. Host and editor ET Wealth Kayezad E Adajania talks to Piyush Gupta, Director at Crisil Intelligence about what 15 years of data across 120 schemes actually shows — the magic of a 10-year SIP, what the COVID crash revealed about short versus long-term investors, why higher returns and more predictable returns are not the same thing, and the basic housekeeping every SIP investor should be doing right now. You can follow Kayezad E Adajania on his social media: X and Linkedin Check out other interesting episodes like: ET Deep Dive: Swipe Left on Reality , India wants manufacturing at 25% of GDP — will AI in factories help? , Tanay Kothari Wants To Kill The Keyboard , From Doer to Director: The LinkedIn Playbook for the AI Agea , Semaglutide Goes Generic: Big Pharma’s Moat Breaks   and much more . Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online , Spotify , Apple…

People in this episode

Host: Kayezad E Adajania

Guest: Piyush Gupta

Topics covered

• SIP investment
• mutual funds
• market crash
• long-term investing
• financial planning

Keywords

• SIP
• mutual funds
• investment duration
• market crash
• financial advice

Mentioned in this episode

Organizations: Crisil Intelligence, ET Wealth, The Economic Times

More episodes of The Morning Brief

• RBI's Rupee Rx · June 11, 2026 · 15 min
• The Gold That Wasn't There: Inside SEBI's Case Against Rajesh Exports · June 9, 2026 · 18 min
• Zia Mody On Law, Legacy and Leadership · June 8, 2026 · 25 min
• ET Deep Dive: Lock, Stock and Worry · June 7, 2026 · 13 min
• Anthropic Goes Public: Can Markets Justify a $1 Trillion Value? · June 5, 2026 · 17 min
• Habil Khorakiwala on India's First FDA-Approved Antibiotic. · June 4, 2026 · 30 min